CompoAtlas

OLIG'ALGIC

Food supplement declared in France, declaration No 2021-12-769

OLIG'ALGIC is a food supplement declared in France. Status: retiré du marché le 20 March 2024. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
Oligosanté
Status
Retiré du marché le 20 March 2024
Form
Gélule
Daily dose
3 gélules par jour
Directions for use
Prendre 3 gélules par jour
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Articulations

Declaration 180821, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Other active ingredients

NamePer day
Palmitoyléthanolamidenot declared

Additives

E460, E470b, Hydroxypropyl Méthyl Cellulose

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Prendre 3 gélules par jour. Utilisation déconseillée en cas de grossesse ou d'allaitement. Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires doivent être utilisés dans le cadre d’un mode de vie sain, et ne pas être utilisés comme substituts d’un régime alimentaire varié et équilibré. A conserver dans un endroit frais, sec et aéré.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line